The anthracycline cardiotoxicity

• Authors: M.Z. Wojtukiewicz , J. Omyla , L. Kozlowski , B. Szynaka
• Languages of publication: PL

Abstracts

EN

The anthracyclines are among the most active and useful anticancer agents, but they are also the most common chemotherapeutics associated with the development of congestive heart failure. Twenty seven to sixy percent of patients with anthracycline-induced cardiomyopathy die of congestive cardiac failure. The paper presents the pathomechanisms of anthracycline-induced cardiotoxicity and perspectives on prevention of congestive heart failure resulting from anthracycline chemiotherapy.

Keywords

EN

ANTHRACYCLINE; CARDIOMYOPATHY; CARDIOTOXICITY

Discipline

• EXPERIMENTAL_BIOLOGY_&_MEDICINE: EXPERIMENTAL BIOLOGY & MEDICINE

• Publisher: Index Copernicus International
• Journal: Postępy Higieny i Medycyny Doświadczalnej
• Year: 2000
• Volume: 54
• Issue: 4
• Pages: 467-485

Contributors

author

M.Z. Wojtukiewicz

author

J. Omyla

author

L. Kozlowski

author

B. Szynaka

• Document Type: ARTICLE
• Publication order reference: M. Z. Wojtukiewicz, Zak?ad Onkologii AM, ul. Ogrodowa 12, 15-027 Bialystok, Poland